Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antifungal Agents

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

Antibody Actions

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

Humoral Immune Responses

Humoral Immune Responses

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effects of human immunoglobulins on <i>Cryptococcus neoformans</i> morphology and proteome.

mBio·2026

Same author

Comparative Analysis of Glucuronoxylomannogalactan and Glucuronoxylomannan Antibody Responses and Their Associations With Cryptococcal Disease Status in People With HIV.

The Journal of infectious diseases·2025

Same author

Shared and unique antibody and B cell profiles in HIV-positive and HIV-negative individuals with cryptococcal meningoencephalitis.

Medical mycology·2023

Same author

Association of Antibody Immunity With Cryptococcal Antigenemia and Mortality in a South African Cohort With Advanced Human Immunodeficiency Virus Disease.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2022

Same author

Reply to Engelthaler and Meyer, "Furthering the Continental Drift Speciation Hypothesis in the Pathogenic <i>Cryptococcus</i> Species Complexes".

mSphere·2017

Same author

Fungi that Infect Humans.

Microbiology spectrum·2017

Search research articles

Related Experiment Video

Updated: May 16, 2026

Automated Measurement of Cryptococcal Species Polysaccharide Capsule and Cell Body

Automated Measurement of Cryptococcal Species Polysaccharide Capsule and Cell Body

Published on: January 11, 2018

Antibody binding to Cryptococcus neoformans impairs budding by altering capsular mechanical properties.

Radames J B Cordero¹, Bruno Pontes, Susana Frases

¹Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Journal of Immunology (Baltimore, Md. : 1950)

|December 13, 2012

Summary

Antibodies binding to microbial capsules physically trap fungal pathogen buds, increasing capsule stiffness. This reveals a novel antibody function in host defense against encapsulated pathogens.

More Related Videos

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans

Published on: February 27, 2018

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Published on: December 19, 2014

Related Experiment Videos

Last Updated: May 16, 2026

Automated Measurement of Cryptococcal Species Polysaccharide Capsule and Cell Body

Automated Measurement of Cryptococcal Species Polysaccharide Capsule and Cell Body

Published on: January 11, 2018

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans

Published on: February 27, 2018

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Published on: December 19, 2014

Area of Science:

Immunology
Microbiology
Biophysics

Background:

Antibody (Ab) binding to microbial capsules is vital for host defense against encapsulated pathogens.
Understanding Ab-capsule interactions is limited due to the fragile nature of capsules and lack of experimental methods.
Existing knowledge primarily focuses on qualitative capsular reactions like 'quellung' effects.

Purpose of the Study:

To investigate the direct effects of antibody binding on the mechanical properties of microbial capsules.
To explore a novel mechanism of antibody function in combating encapsulated pathogens.
To pioneer new experimental methodologies for studying fragile microbial structures.

Main Methods:

Utilized optical tweezers microscopy, a novel approach for studying Ab-capsule interactions.
Investigated the binding of protective monoclonal antibodies (mAbs) to the capsule of *Cryptococcus neoformans*.
Assessed changes in capsular mechanical properties, including stiffness and budding impairment.

Main Results:

Monoclonal antibody (mAb) binding to *Cryptococcus neoformans* capsules impaired yeast budding by physically trapping emerging buds.
Demonstrated a concentration-dependent increase in capsule stiffness mediated by mAb binding.
Showed that increased stiffness resulted from mAb-mediated cross-linking of capsular polysaccharide molecules.

Conclusions:

Antibody binding can directly alter the mechanical properties of microbial capsules, leading to functional impairment of the pathogen.
Identified a nonclassical mechanism of antibody function involving physical manipulation of the capsule.
Provided evidence for direct antimicrobial functions of antibodies independent of other immune system components, applicable to various encapsulated pathogens.